Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies

Gene
Pamela H CorrellXin Wei

Abstract

Dysregulation of receptor tyrosine kinase (RTK) activity has been implicated in the progression of a variety of human leukemias. Most notably, mutations and chromosomal translocations affecting regulation of tyrosine kinase activity in the Kit receptor, the Flt3 receptor, and the PDGFbeta/FGF1 receptors have been demonstrated in mast cell leukemia, acute myeloid leukemia (AML), and chronic myelogenous leukemias (CML), respectively. In addition, critical but non-overlapping roles for the Ron and Kit receptor tyrosine kinases in the progression of animal models of erythroleukemia have been demonstrated [Persons, D., Paulson, R., Loyd, M., Herley, M., Bodner, S., Bernstein, A., Correll, P. and Ney, P., 1999. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat. Gen. 23, 159-165.; Subramanian, A., Teal, H.E., Correll, P.H. and Paulson, R.F., 2005. Resistance to friend virus-induced erythroleukemia in W/Wv mice is caused by a spleen-specific defect which results in a severe reduction in target cells and a lack of Sf-Stk expression. J. Virol. 79 (23), 14586-14594.]. The various classes of RTKs implicated in the progression of leukemia have been recently reviewed [Reilly, J., 2003. Receptor tyrosine kinases in normal ...Continue Reading

References

Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·N R SomanG N Wogan
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D R SmithM J Hayman
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W Y LangdonH C Morse
Jul 1, 1995·Trends in Biochemical Sciences·P van der Geer, T Pawson
Feb 16, 1996·The Journal of Biological Chemistry·Y MoriyamaY Kanakura
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·X PiaoA Bernstein
Jan 15, 1997·The EMBO Journal·M A LemmonJ Schlessinger
May 1, 1997·Molecular Biology of the Cell·G M Lesa, P W Sternberg
Jun 20, 1998·The Journal of Biological Chemistry·S R HubbardJ Schlessinger
Aug 26, 1998·Cell·A Weiss, J Schlessinger
May 14, 1999·Current Biology : CB·P M Holland, J A Cooper
Jun 25, 1999·Cell·T Pawson, T M Saxton
Feb 23, 2000·The Journal of Clinical Investigation·W S Pear
Jun 28, 2000·The Journal of Cell Biology·U SchaeperW Birchmeier
Jul 27, 2000·Molecular and Cellular Biology·J C ArevaloP Perez
Aug 31, 2000·Annual Review of Biochemistry·S R Hubbard, J H Till
Aug 4, 2001·Molecular and Cellular Biology·A Danilkovitch-MiagkovaE J Leonard
Dec 26, 2001·Oncogene·D DiMaio, D Mattoon
Jul 19, 2002·Cancer Cell·Martin SattlerBenjamin G Neel

❮ Previous
Next ❯

Citations

Sep 9, 2011·Current Treatment Options in Oncology·Gabriela Motyckova, Richard M Stone
Oct 6, 2012·Leukemia·O H KrämerS K Knauer
Oct 24, 2007·Molecular & Cellular Proteomics : MCP·Andrew PierceAnthony D Whetton
Jan 23, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alicia KlattAndrew J Henderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.